HIV group N case detected outside Cameroon for the first time
November 24, 2011 in HIV & AIDS
A rare type of HIV-infection -- group N -- has been diagnosed in a man in France who recently travelled to Togo, meaning that it has been detected outside Cameroon for the first time. This type of HIV infection is much more similar to the virus type found in chimpanzees than it is to other types circulating in humans. The circumstances are described in a Case Report in this week's issue of the Lancet, written by Professor François Simon, INSERM U 941, Faculté de Médecine Paris-Diderot, Hôpital Saint-Louis, Paris and colleagues from the National Reference Centre for HIV, Rouen, France.
Most types of HIV in humans are either group M, or less commonly, group O. The first case of group N was diagnosed in a woman living in Cameroon in 1998, and since then only 12 cases, including two couples infected by the same strains, have been identified, all in Cameroon. In 2009, a fourth group, designated as P, was identified in a Cameroonian woman living Paris.
In this new group N case, a 57-year-old man living in France attended an emergency unit Hôpital Saint-Louis with fever, rash, swollen lymph glands, and genital ulceration, 8 days after returning from Togo. He reported sexual contact with a Togolese partner, and HIV primary infection was suspected. Once HIV was detected, it was profiled and the authors say they were surprised to see that the virus did not match up with standard types.
They add that this case of primary HIV-N infection is particularly important because the severe clinical manifestations and early decline in CD4 cell count. A five-drug antiretroviral combination showed good initial efficacy, but longer-term immunological and virological follow-up is needed.
The authors conclude: "This case of HIV-1 group-N primary infection indicates that this rare group is now circulating outside Cameroon, which emphasises the need for rigorous HIV epidemiological monitoring."
More information: Paper online: www.thelancet.com/… 7-8/abstract
Provided by Lancet
-
Gorillas are new source of HIV, scientists reveal
Aug 02, 2009 |
not rated yet |
0
-
Chronic HIV-1 infection frequently fails to protect against superinfection
Nov 16, 2007 |
not rated yet |
0
-
Is HIV testing during labor feasible?
Feb 27, 2009 |
not rated yet |
0
-
Researchers discover new details about HIV-1 entry and infection
Feb 15, 2007 |
not rated yet |
0
-
HIV isolate from Kenya provides clues for vaccine design
Jan 02, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
HIV & AIDS
May 24, 2013 |
5 / 5 (3) |
0
|
New microsphere-based methods for detecting HIV antibodies
Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies ...
HIV & AIDS
May 23, 2013 |
5 / 5 (1) |
0
Fecal microbiota tx feasible for recurrent C. difficile in HIV
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Intern ...
HIV & AIDS
May 22, 2013 |
not rated yet |
0
Canada lifts ban on gay men donating blood
Canadian health authorities lifted Wednesday what was effectively a ban on gay men giving blood, announcing new rules making men who have not had sex with men in the past five years eligible.
HIV & AIDS
May 22, 2013 |
not rated yet |
1
AIDS scientists optimistic of AIDS cure, for some
Top AIDS scientists were optimistic Wednesday of finding a cure for the disease that has claimed 30 million lives—but said it might not work for all people.
HIV & AIDS
May 22, 2013 |
not rated yet |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.